Brought to you by 
Centagenetix teams with Boston U. in centenarian studies
13 Jan 2003
Executive Summary
Centagenetix (genetics associated with aging) has teamed up with Boston University and the Boston Medical Center to research diseases of aging and potentially develop products to delay the aging process in humans.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Product or Technology Swap
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com